These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 23856419

  • 1. Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.
    Bigg PW, Baldo G, Sleeper MM, O'Donnell PA, Bai H, Rokkam VR, Liu Y, Wu S, Giugliani R, Casal ML, Haskins ME, Ponder KP.
    Mol Genet Metab; 2013 Nov; 110(3):319-28. PubMed ID: 23856419
    [Abstract] [Full Text] [Related]

  • 2. The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade.
    Bigg PW, Sleeper MM, O'Donnell PA, Liu Y, Wu S, Casal ML, Haskins ME, Ponder KP.
    Mol Genet Metab; 2013 Nov; 110(3):311-8. PubMed ID: 23860311
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
    Sleeper MM, Fornasari B, Ellinwood NM, Weil MA, Melniczek J, O'Malley TM, Sammarco CD, Xu L, Ponder KP, Haskins ME.
    Circulation; 2004 Aug 17; 110(7):815-20. PubMed ID: 15289379
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.
    Metcalf JA, Linders B, Wu S, Bigg P, O'Donnell P, Sleeper MM, Whyte MP, Haskins M, Ponder KP.
    Mol Genet Metab; 2010 Apr 17; 99(4):396-407. PubMed ID: 20044292
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.
    Smith LJ, Baldo G, Wu S, Liu Y, Whyte MP, Giugliani R, Elliott DM, Haskins ME, Ponder KP.
    Mol Genet Metab; 2012 Sep 17; 107(1-2):153-60. PubMed ID: 22513347
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs.
    Ponder KP, Melniczek JR, Xu L, Weil MA, O'Malley TM, O'Donnell PA, Knox VW, Aguirre GD, Mazrier H, Ellinwood NM, Sleeper M, Maguire AM, Volk SW, Mango RL, Zweigle J, Wolfe JH, Haskins ME.
    Proc Natl Acad Sci U S A; 2002 Oct 01; 99(20):13102-7. PubMed ID: 12232044
    [Abstract] [Full Text] [Related]

  • 7. Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs.
    Smith LJ, Martin JT, O'Donnell P, Wang P, Elliott DM, Haskins ME, Ponder KP.
    Mol Genet Metab; 2012 Sep 01; 107(1-2):145-52. PubMed ID: 22510705
    [Abstract] [Full Text] [Related]

  • 8. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
    Mango RL, Xu L, Sands MS, Vogler C, Seiler G, Schwarz T, Haskins ME, Ponder KP.
    Mol Genet Metab; 2004 May 01; 82(1):4-19. PubMed ID: 15110316
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.
    Baldo G, Wu S, Howe RA, Ramamoothy M, Knutsen RH, Fang J, Mecham RP, Liu Y, Wu X, Atkinson JP, Ponder KP.
    Mol Genet Metab; 2011 Dec 01; 104(4):608-19. PubMed ID: 21944884
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.
    Gurda BL, De Guilhem De Lataillade A, Bell P, Zhu Y, Yu H, Wang P, Bagel J, Vite CH, Sikora T, Hinderer C, Calcedo R, Yox AD, Steet RA, Ruane T, O'Donnell P, Gao G, Wilson JM, Casal M, Ponder KP, Haskins ME.
    Mol Ther; 2016 Feb 01; 24(2):206-216. PubMed ID: 26447927
    [Abstract] [Full Text] [Related]

  • 11. Large proteoglycan complexes and disturbed collagen architecture in the corneal extracellular matrix of mucopolysaccharidosis type VII (Sly syndrome).
    Young RD, Liskova P, Pinali C, Palka BP, Palos M, Jirsova K, Hrdlickova E, Tesarova M, Elleder M, Zeman J, Meek KM, Knupp C, Quantock AJ.
    Invest Ophthalmol Vis Sci; 2011 Aug 24; 52(9):6720-8. PubMed ID: 21743015
    [Abstract] [Full Text] [Related]

  • 12. The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.
    Xing EM, Knox VW, O'Donnell PA, Sikura T, Liu Y, Wu S, Casal ML, Haskins ME, Ponder KP.
    Mol Genet Metab; 2013 Jun 24; 109(2):183-93. PubMed ID: 23628461
    [Abstract] [Full Text] [Related]

  • 13. Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
    Wang B, O'Malley TM, Xu L, Vite C, Wang P, O'Donnell PA, Ellinwood NM, Haskins ME, Ponder KP.
    Mol Genet Metab; 2006 Jan 24; 87(1):8-21. PubMed ID: 16275036
    [Abstract] [Full Text] [Related]

  • 14. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
    Peck SH, O'Donnell PJ, Kang JL, Malhotra NR, Dodge GR, Pacifici M, Shore EM, Haskins ME, Smith LJ.
    Mol Genet Metab; 2015 Nov 24; 116(3):195-203. PubMed ID: 26422116
    [Abstract] [Full Text] [Related]

  • 15. Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII.
    Sammarco C, Weil M, Just C, Weimelt S, Hasson C, O'Malley T, Evans SM, Wang P, Casal ML, Wolfe J, Haskins M.
    Bone Marrow Transplant; 2000 Jun 24; 25(12):1289-97. PubMed ID: 10871735
    [Abstract] [Full Text] [Related]

  • 16. Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII.
    Donsante A, Levy B, Vogler C, Sands MS.
    J Inherit Metab Dis; 2007 Apr 24; 30(2):227-38. PubMed ID: 17308887
    [Abstract] [Full Text] [Related]

  • 17. The effect of Tlr4 and/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII mice.
    Xing EM, Wu S, Ponder KP.
    Mol Genet Metab; 2015 Feb 24; 114(2):209-16. PubMed ID: 25559179
    [Abstract] [Full Text] [Related]

  • 18. Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.
    Serratrice N, Cubizolle A, Ibanes S, Mestre-Francés N, Bayo-Puxan N, Creyssels S, Gennetier A, Bernex F, Verdier JM, Haskins ME, Couderc G, Malecaze F, Kalatzis V, Kremer EJ.
    J Control Release; 2014 May 10; 181():22-31. PubMed ID: 24607662
    [Abstract] [Full Text] [Related]

  • 19. Adenoviral vector-mediated beta-glucuronidase cDNA transfer to treat MPS VII RPE in vitro.
    Verdugo ME, Scarpino V, Moullier P, Haskins ME, Aguirre GD, Ray J.
    Curr Eye Res; 2001 Nov 10; 23(5):357-67. PubMed ID: 11910525
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.